Home > Products > Pharmaceuticals & Life Science > Pharmaceutical Intermediates > (3R)-2'-(4-Bromo-2-fluorobenzyl)spiro[pyrrolidine-3,4'-1'H-pyrrolo[1,2-a]pyrazine]-1',2,3',5(2'H)-tetraone
(3R)-2'-(4-Bromo-2-fluorobenzyl)spiro[pyrrolidine-3,4'-1'H-pyrrolo[1,2-a]pyrazine]-1',2,3',5(2'H)-tetraone structure, CAS 147254-64-6

(3R)-2'-(4-Bromo-2-fluorobenzyl)spiro[pyrrolidine-3,4'-1'H-pyrrolo[1,2-a]pyrazine]-1',2,3',5(2'H)-tetraone

CAS Number147254-64-6

SynonymsRanirestat; Ranirestat (JAN/INN); SX-3202; AS-3201; SX 3030

Molecular FormulaC17H11BrFN3O4

Molecular Weight420.19

Purity≥97 (HPLC)%

Density1.83g/cm3

Boiling Point702.7ºC at 760mmHg

Melting Point

Flash Point

Appearancepowder

EINECS

MSDSChineseEnglish

Symbol

Signal Word

Cat. No.: 2A-9093656 Purity: ≥97 (HPLC)%
Change View

Please Login or Create an Account to: See VlP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

Quality Control of [ 147254-64-6 ] Purity: ≥97 (HPLC)% SDS Specification MoL

Chemical & Physical Properties
CAS Number147254-64-6
Catalog No.2A-9093656
Chinese Name雷尼司他
SynonymsRanirestat; Ranirestat (JAN/INN); SX-3202; AS-3201; SX 3030
Molecular FormulaC17H11BrFN3O4
Molecular Weight420.19
Purity≥97 (HPLC)
Density1.83g/cm3
Boiling Point702.7ºC at 760mmHg
Appearancepowder
Storage Condition2-8℃
ApplicationRanirestat (AS-3201) is an aldose reductase inhibitor, clinical phase 3 for diabetic neuropathy.
PubChem ID329825780
MDL NumberMFCD00920915
SMILESO=C(N1CC2=C(F)C=C(Br)C=C2)C3=CC=CN3[C@@]4(CC(NC4=O)=O)C1=O
InChI1S/C17H11BrFN3O4/c18-10-4-3-9(11(19)6-10)8-21-14(24)12-2-1-5-22(12)17(16(21)26)7-13(23)20-15(17)25/h1-6H,7-8H2,(H,20,23,25)/t17-/m1/s1
InChI KeyQCVNMNYRNIMDKV-QGZVFWFLSA-N
NACRES CodeNA.77
UNSPSC12352200
MSDSmsds/93656_1_147254_64_6.pdf
Transport InfoProduct Name: Rannisstat
Contact Us

Phone:

630-322-8886

630-322-8887

Email:

[email protected]

Office Locations:

Chicago, IL, USA

San Francisco, CA, USA